top of page


ACP-105 is a selective androgen receptor modulator (SARM) designed as a treatment for individuals with degenerative bone disorders. In studies it has been used for patients with arthritis and osteoporosis. It was designed to be a safer alternative to steroids and prohormones.  It is estimated to have a 1:3 androgenic to anabolic ratio. As ACP-105 is only a partial agonsits suggesting suppression of dominants hormones is low compared to steroids'. More resaerch is required to conclude the benefits and risks associated wit ACP-105.

Look for more great information about SARMs, peptides, nootropics and research hair loss products on our blog. 
bottom of page